First Horizon Corporation’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$47K Hold
350
﹤0.01% 394
2021
Q1
$47K Buy
350
+200
+133% +$29.9K ﹤0.01% 386
2020
Q4
$21K Hold
150
﹤0.01% 514
2020
Q3
$16K Buy
+150
New +$16.8K ﹤0.01% 542
2013
Q2
$42K Buy
+1,200
New +$42.2K 0.01% 349

Other funds holding XBI

First Horizon Corporation's XBI Position: Q2 2021 in Review

First Horizon Corporation held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2021 at 350 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #394.

First Horizon Corporation first reported a position in XBI in Q2 2013 and has held it in 5 quarters since. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

  • First Horizon Corporation held 350 shares of State Street SPDR S&P Biotech ETF worth $47K as of Q2 2021.
  • First Horizon Corporation left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2021.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #394 holding.
  • First Horizon Corporation first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 5 quarters since.
  • 663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.